Glenmark to raise Rs 945 cr from Temasek Holdings - (Business Standard via NewsPoints Desk)

  • Business Standard reported that Glenmark Pharmaceuticals plans to raise up to Rs 945 crore by issuing over one crore shares to Temasek Holdings, the investment arm of the Singapore government, on a preferential basis.
  • "We are pleased that one of the world's most reputed financial institutions, Temasek Holdings, is considering investment in the company," said Glenmark chairman Glenn Saldanha.
  • He added that the drugmaker remains committed to investing significantly in building a strong product pipeline across geographies.

To read more NewsPoints articles, click here.

Reference Articles